Tosi Gian Marco

Rubegni Giovanni, Ferri Paolo, Mocciardini Emanuele, Mapelli Luca, Savaresi Gaetano, Prandini Rebecca et al.

A smartphone-driven AR headset significantly improved visual field and low-light mobility in RP patients, offering a scalable, affordable rehabilitation alternative.

Spini Andrea, Giometto Sabrina, Donnini Sandra, Posarelli Matteo, Dotta Francesco, Ziche Marina et al.

This study found bevacizumab and ranibizumab injections carried a higher risk of intraocular pressure increase than aflibercept, suggesting differential glaucoma risk among anti-VEGF agents.

Tosi Gian Marco, Balestrazzi Angelo, Baiocchi Stefano, Tarantello Antonio, Cevenini Gabriele, Marigliani Davide et al.

Comparing pre-vitrectomy cataract surgery to combined phacovitrectomy for complex retinal detachment showed similar visual/anatomical outcomes, though pre-vitrectomy had less posterior synechia. Both approaches are effective.

Tosi Gian Marco, Caldi Elena, Neri Giovanni, Nuti Elisabetta, Marigliani Davide, Baiocchi Stefano et al.

This study found elevated HTRA1 and TGF-β1 in neovascular AMD aqueous humor; HTRA1 normalized with anti-VEGF, but TGF-β1 remained high, suggesting its persistent role independent of VEGF in AMD pathogenesis.

Martone Gianluca, Frezzotti Paolo, Tosi Gian Marco, Traversi Claudio, Mittica Vincenzo, Malandrini Alex et al.

Preservative-containing glaucoma drops significantly damage the corneal surface and nerves compared to preservative-free drops. This highlights the need for less toxic treatments to improve patient comfort and adherence.

Traversi Claudio, Bianciardi Giorgio, Tasciotti Annalisa, Berni Elisa, Nuti Elisabetta, Luzi Pietro et al.

This study found optic nerve head vascular complexity (fractal dimension) was significantly higher in NAION and optic neuritis eyes than controls, suggesting altered microvasculature in these conditions.

Tosi Gian Marco, Schiff William, Barile Gaetano, Yoshida Norihiko, Chang Stanley

Intravitreal viscoelastic injections effectively raised eye pressure in severe hypotony cases, improving vision. This offers a promising treatment for low eye pressure.